Among 342 patients remaining DCIS after surgery, there were 45 patients with unknown ER, PR status, 175 patients with unknown or uncertain in HER2 status, and 48 patients having unknown results for the Ki-67. This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.